Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.

<h4>Background</h4>In sub-Saharan Africa (SSA), adolescent girls and young women (AGYW) ages 15 to 24 years represent <10% of the population yet account for 1 in 5 new HIV infections. Although oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/F...

Full description

Bibliographic Details
Main Authors: Jean de Dieu Tapsoba, Jane Cover, Christopher Obong'o, Martha Brady, Tim R Cressey, Kira Mori, Gordon Okomo, Edward Kariithi, Rael Obanda, Daniel Oluoch-Madiang, Ying Qing Chen, Paul Drain, Ann Duerr
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-09-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004097